(Q46574072)

23 December 2017

title

Increased orocecal transit time in patients with nonalcoholic fatty liver disease (English)

1 reference

23 December 2017

metabolic dysfunction–associated steatotic liver disease

main subject

1 reference

Alejandro Soza

1

1 reference

23 December 2017

Arnoldo Riquelme

2

1 reference

23 December 2017

Robinson González

3

1 reference

23 December 2017

Manuel Alvarez

4

1 reference

23 December 2017

Rosa María Pérez-Ayuso

5

1 reference

23 December 2017

Juan Carlos Glasinovic

6

1 reference

23 December 2017

Marco Arrese

7

1 reference

23 December 2017

publication date

1 June 2005

1 reference

23 December 2017

Digestive Diseases and Sciences

published in

1 reference

23 December 2017

volume

50

1 reference

23 December 2017

issue

6

1 reference

23 December 2017

page(s)

1136-1140

1 reference

23 December 2017

https://scigraph.springernature.com/pub.10.1007/s10620-005-2720-8

exact match

0 references

cites work

Degradation of endogenous bacterial cell wall polymers by the muralytic enzyme mutanolysin prevents hepatobiliary injury in genetically susceptible rats with experimental intestinal bacterial overgrowth

1 reference

12 December 2020

Non-alcoholic steatohepatitis associated with small intestinal diverticulosis and bacterial overgrowth

1 reference

12 December 2020

Nonalcoholic fatty liver disease

1 reference

12 December 2020

A 13-year review of jejunoileal bypass

1 reference

12 December 2020

[The H2-lactulose breath test in the diagnosis of intestinal transit time]

1 reference

12 December 2020

Nonalcoholic fatty liver disease

1 reference

12 December 2020

Using breath tests wisely in a gastroenterology practice: an evidence-based review of indications and pitfalls in interpretation

1 reference

12 December 2020

The natural history of nonalcoholic fatty liver disease: a clinical histopathological study

1 reference

12 December 2020

The effect of aging on oro-cecal transit time in normal subjects and patients with gallstone disease.

1 reference

12 December 2020

Endogenous endotoxin-core antibody (EndoCAb) as a marker of endotoxin exposure and a prognostic indicator: a review

1 reference

12 December 2020

Long-Term treatment with cisapride and antibiotics in liver cirrhosis: effect on small intestinal motility, bacterial overgrowth, and liver function

1 reference

12 December 2020

The Lactulose Hydrogen Breath Test as a Diagnostic Test for Small-Bowel Bacterial Overgrowth

1 reference

12 December 2020

Orocecal transit delay in obese patients

1 reference

12 December 2020

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

1 reference

12 December 2020

Nonalcoholic steatohepatitis: definition and pathology

1 reference

12 December 2020

Eradication of small intestinal bacterial overgrowth and oro-cecal transit in diabetics.

1 reference

12 December 2020

Is bacterial ash the flash that ignites NASH?

1 reference

12 December 2020

Effect of cisapride on intestinal bacterial overgrowth and bacterial translocation in cirrhosis

1 reference

12 December 2020

Small intestinal bacterial overgrowth, intestinal permeability, and non-alcoholic steatohepatitis

1 reference

12 December 2020

Defining nonalcoholic fatty liver disease: implications for epidemiologic studies

1 reference

12 December 2020

Steatohepatitis: a tale of two "hits"?

1 reference

12 December 2020

The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis

1 reference

12 December 2020

Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease

1 reference

12 December 2020

10.1007/S10620-005-2720-8

Identifiers

DOI

1 reference

23 December 2017

PubMed ID

15986870

1 reference

23 December 2017